ILLUMINA INC (ILMN)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ILMN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ILMN | CFO at Edwards Lifesciences; Director; Chair | 59 | ["Financial Expert","Chief Financial Officer, Edwards Lifesciences","CFO Bemis Company, Inc.","Managing Director at Bank of America","Managing Director at Goldman Sachs","Henry Crown Fellow at the Aspen Institute","CFO at Edwards Lifesciences"] | ["Audit"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| EW | Corporate Vice President, Chief Financial Officer | 56 | ["Executive responsibility for information technology, risk management, and corporate services", "Former Chief Financial Officer of Bemis Company Inc.", "17 years in investment banking at Goldman Sachs and Bank of America"] | ["compensation committee", "audit committee", "capital allocation committee"] | 2023 |
Biography sourced from the proxy statement filing.
Director since 2023 Financial Expert Age: 59 Board Committees Audit (Chair) Education B.A. in Political Science from DePauw University MBA from Harvard Business School Relevant Expertise Mr. Ullem s financial oversight capabilities, especially as CFO of large, global public companies and as an investment banker, significantly enhances the Board oversight of financial reporting and capital allocation. In addition, Mr. Ullem is an audit committee financial expert under applicable SEC rules. Career Highlights Chief Financial Officer, Edwards Lifesciences (since 2014) (1) Various positions including Chief Financial Officer Bemis Company, Inc. (2008 2013) Managing Director, Co-Head of Diversified Industries Investment Banking at Bank of America (2005 2008) Various positions including Managing Director at Goldman Sachs (1989 2005) Public Board Service Berry Global Corp. (2016 2024) Non-Public Board Service egnite, a digital health technology company (since 2021) Of Note Henry Crown Fellow at the Aspen Institute (1) Mr. Ullem announced on October 30, 2025 that he would be transitioning from his role by midyear 2026. Following the appointment of a new CFO, Mr. Ullem will continue in an advisory role at Edwards Lifesciences.